<DOC>
	<DOC>NCT00470665</DOC>
	<brief_summary>The purpose of this study is to assess whether in high-risk kidney transplant patients (patients whose previous kidney transplant failed, have a high PRA lab test result or are of African-American descent) that a combination of Rapamune with Prograf and steroids will prevent acute rejection as well as Rapamune and cyclosporine and steroids.</brief_summary>
	<brief_title>Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Inclusion criteria: Patients of AfricanAmerican descent or patient with a history of multiple transplants and/or patients with a high panel reactive antibody lab test with a renal transplant from a cadaveric donor, a living unrelated donor or a livingrelated mismatched donor. Age &gt;= 13 years, weight &gt;= 40 kg Women must have a negative pregnancy test at study entry Exclusion criteria Multiple organ transplants or double kidney transplants (pediatric enbloc or double adult) Active systemic infection, or localized major infection or known HIV Patients with residual kidney function &gt;20 mL/min</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>